ACADIA Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Welcome, everyone, to the 41st Annual JPMorgan Healthcare Conference. My name is Tess Romero. I'm one of the biotech analysts here at JPMorgan. I'm joined by Taylor Hanley and (inaudible) from the team.
Our next presenting company is ACADIA. And speaking on behalf of the company, we have CEO, Steve Davis. Before I turn it over to Steve, I just wanted to highlight that we do have a Q&A session after this formal presentation. There's an Ask A Question button in the portal for those that would like to submit in a question or we will have mic runners to take live questions as well.
So with that, I'm going to hand it over to Steve.
Great. Thanks so much, Tessa, and thanks to each of you for weathering the conditions getting over here, we had a little rise in the rain. So hopefully, you all made it over dry this morning, and thanks to each of you who are joining remotely.
I need to start with
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |